InFACT – an International Forum for Acute Care Trialists – is a collaborative network of investigator-led research groups that study the optimal care of acutely ill patients, from their initial presentation in the community through their support in the intensive care unit (ICU) to their rehabilitation and integration back into society.
InFACT is guided by a Steering Committee of representatives of the various research groups that have recognized the value of closer international collaboration to advance the study of the care of the acutely ill. These groups come from around the world, and include the Acute Respiratory Distress Syndrome Network (ARDSNet), the Australia and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group, the Canadian Critical Care Trials Group, the Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva GiViTI Network, the Irish Critical Care Trials Group, the Latin American Sepsis Institute, the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network, the Scandinavian Critical Care Trials Group, the Scottish Critical Care Trials Group, the SepNet Investigators of the German Sepsis Society, and the United States Critical Illness and Injury Trials Group (USCIITG) among others. These organizations have come together to build a collegial, vibrant, and scientifically rigorous collaboration which will emerge as a formal network of networks over the coming months.
But while we have been engaging in discussions to create an inclusive global forum for acute care researchers, the evolving H1N1 pandemic has confronted us with an extraordinary challenge and an unprecedented opportunity, and we have banded together to respond.